Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.
about
Epstein-Barr virus and the origin of Hodgkin lymphomaEpstein-Barr virus latent genesThe viral latency-associated nuclear antigen augments the B-cell response to antigen in vivoAlzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune SystemCross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virusModulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.Instigation of Notch signaling in the pathogenesis of Kaposi's sarcoma-associated herpesvirus and other human tumor viruses.The challenge of targeting notch in hematologic malignancies.Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.The Epstein-Barr virus microRNA BART11-5p targets the early B-cell transcription factor EBF1.Evidence for regulation of oxidative stress by latent membrane protein 1 oncoprotein in patients with low-grade leukemic B cell lymphoma with latent Epstein-Barr virus infection.
P2860
Q26998999-C90CA753-4C5C-435C-B655-EAD09D30FBAAQ28082701-778325D0-734F-46B7-969E-8FD7D82D7B6EQ34178308-EEC36A92-3DFB-4E26-BC4B-A4A0FD3436AFQ35664117-1CDA44A7-477A-43B7-92CA-3BF626CD633BQ36346985-4608A241-4F32-4AFB-B92A-611362A5DB75Q37399274-57D87F54-8883-4238-AD5E-A127C6A424EEQ37713982-1DDB1415-DAE1-4971-9185-A7982D4FB2BBQ37726624-951BDE64-28CA-4442-92DA-86DE42322B8CQ37810431-A99BAB7E-5EF5-4C7E-9A63-DFC35651A765Q38048861-A5A02ABA-1F13-41E3-895C-32C0C9BDA942Q38222770-98D61947-E9AF-4815-9FF7-2CE392CEC85DQ38966100-EF8CF617-FFFF-4E4E-96BF-42FC89A666F0Q39806231-E73D05F0-D8DF-4327-B3AD-73403620565DQ40134553-8322C354-3BCF-40E4-940B-4FF651B18150Q42254006-D8F9A8D8-B34F-4261-ABDC-E7D071909E4A
P2860
Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epstein-Barr virus latent memb ...... alter B-cell identity in vivo.
@en
Epstein-Barr virus latent memb ...... alter B-cell identity in vivo.
@nl
type
label
Epstein-Barr virus latent memb ...... alter B-cell identity in vivo.
@en
Epstein-Barr virus latent memb ...... alter B-cell identity in vivo.
@nl
prefLabel
Epstein-Barr virus latent memb ...... alter B-cell identity in vivo.
@en
Epstein-Barr virus latent memb ...... alter B-cell identity in vivo.
@nl
P2860
P1433
P1476
Epstein-Barr virus latent memb ...... alter B-cell identity in vivo.
@en
P2093
Leah J Anderson
Richard Longnecker
P2860
P304
P356
10.1182/BLOOD-2008-06-160937
P407
P577
2008-09-24T00:00:00Z